Mutations of the Walker B motif in the first nucleotide binding domain of multidrug resistance protein MRP1 prevent conformational maturation

被引:23
|
作者
Cui, LY [1 ]
Hou, YX [1 ]
Riordan, JR [1 ]
Chang, XB [1 ]
机构
[1] Mayo Clin Scottsdale, SC Johnson Med Res Ctr, Scottsdale, AZ 85259 USA
关键词
MRP1; nucleotide binding domain (NBD); conformational maturation; proteasome; trypsin digestion; photoaffinity labeling; ATP-dependent LTC4 uptake;
D O I
10.1006/abbi.2001.2441
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
ATP-binding cassette (ABC) transporters couple the binding and hydrolysis of ATP to the translocation of solutes across biological membranes. The so-called "Walker motifs" in each of the nucleotide binding domains (NBDs) of these proteins contribute directly to the binding and the catalytic site for the MgATP substrate. Hence mutagenesis of residues in these motifs may interfere with function. This is the case with the MRP1 multidrug transporter. However, interpretation of the effect of mutation in the Walker B motif of NBD1 (D792L/D793L) was confused by the fact that it prevented biosynthetic maturation of the protein. We have determined now that this latter effect is entirely due to the D792L substitution. This variant is unable to mature conformationally as evidenced by its remaining more sensitive to trypsin digestion in vitro than the mature wild-type protein. In vivo, the core-glycosylated form of that mutant is retained in the endoplasmic reticulum and degraded by the proteasome. A different substitution of the same residue (D792A) had a less severe effect enabling accumulation of approximately equal amounts of mature and immature MRP1 proteins in the membrane vesicles but still resulted in defective nucleotide interaction and organic anion transport, indicating that nucleotide hydrolysis at NBD1 is essential to MRP1 function. (C) 2001 Academic Press.
引用
收藏
页码:153 / 161
页数:9
相关论文
共 50 条
  • [1] ATP binding to the first nucleotide-binding domain of multidrug resistance protein MRP1 increases binding and hydrolysis of ATP and trapping of ADP at the second domain
    Hou, YX
    Cui, LY
    Riordan, JR
    Chang, XB
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (07) : 5110 - 5119
  • [2] Nonequivalent nucleotide trapping in the two nucleotide binding folds of the human multidrug resistance protein MRP1
    Nagata, K
    Nishitani, M
    Matsuo, M
    Kioka, N
    Amachi, T
    Ueda, K
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (23) : 17626 - 17630
  • [3] Targeting Nucleotide Binding Domain of Multidrug Resistance-associated Protein-1 (MRP1) for the Reversal of Multi Drug Resistance in Cancer
    Dhasmana, Divya
    Singh, Ashutosh
    Shukla, Rohit
    Tripathi, Timir
    Garg, Neha
    SCIENTIFIC REPORTS, 2018, 8
  • [4] Targeting Nucleotide Binding Domain of Multidrug Resistance-associated Protein-1 (MRP1) for the Reversal of Multi Drug Resistance in Cancer
    Divya Dhasmana
    Ashutosh Singh
    Rohit Shukla
    Timir Tripathi
    Neha Garg
    Scientific Reports, 8
  • [5] ATP binding, not hydrolysis, at the first nucleotide-binding domain of multidrug resistance-associated protein MRP1 enhances ADP-Vi trapping at the second domain
    Hou, YX
    Riordan, JR
    Chang, XB
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (06) : 3599 - 3605
  • [6] Identification and characterization of human multidrug resistance protein 1 (MRP1) mutations
    Conrad, S
    Kauffmann, HM
    Ito, K
    Leslie, EM
    Deeley, RG
    Cole, SPC
    Schrenk, D
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2002, 365 : R161 - R161
  • [7] Secondary and tertiary structure changes of reconstituted multidrug resistance protein (MRP1) induced by nucleotide and drug binding
    Manciu, L
    Chang, XB
    Riordan, JR
    Ruysschaert, JM
    BIOPHYSICAL JOURNAL, 2002, 82 (01) : 525A - 525A
  • [8] Peptide transport by the multidrug resistance protein MRP1
    de Jong, MC
    Slootstra, JW
    Scheffer, GL
    Schroeijers, AB
    Puijk, WC
    Dinkelberg, R
    Kool, M
    Broxterman, HJ
    Meloen, RH
    Scheper, RJ
    CANCER RESEARCH, 2001, 61 (06) : 2552 - 2557
  • [9] ATPase activity of the first nucleotide-binding domain (NBD1) of the multidrug resistance-associated protein (MRP).
    Wilkes, DM
    Altenberg, GA
    FASEB JOURNAL, 1999, 13 (07): : A1525 - A1525
  • [10] Allosteric interactions between the two non-equivalent nucleotide binding domains of multidrug resistance protein MRP1
    Hou, YX
    Cui, LY
    Riordan, JR
    Chang, XB
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (27) : 20280 - 20287